To include your compound in the COVID-19 Resource Center, submit it here.

Exelon neurology data

Data from a placebo-controlled trial in 541 PD patients showed that Exelon led to better overall

Read the full 167 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE